Skip to content

Bacteriostatic Saline as a Local Anesthetic in Minor Eyelid Procedures

Bacteriostatic Saline as a Local Anesthetic in Minor Eyelid Procedures

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05294640
Enrollment
95
Registered
2022-03-24
Start date
2022-05-17
Completion date
2023-02-21
Last updated
2025-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Local, Eyelid Abscess, Eyelid Boil, Eyelid Bump, Eyelid Deformity, Eyelid Papilloma, Eyelid Tumor, Ophthalmology

Keywords

Oculoplastics, Local Anesthesia, Eyelid Anesthesia, Periocular Anesthesia

Brief summary

The investigators aim to assess whether bacteriostatic saline provides the same level of anesthesia as traditional local anesthesia while reducing pain associated with medication infusion in minor eyelid procedures

Detailed description

Benzoyl alcohol is an aromatic alcohol that has been used in healthcare primarily as an antibacterial preservative agent in bacteriostatic saline. It has also been shown to have anesthetic properties, and has been demonstrated to cause less pain with infusion compared to lidocaine, while maintaining adequate pain relief. The use of bacteriostatic saline alone as an anesthetic for incisional procedures in the periocular area has not yet been studied. The purpose of this study was to determine whether bacteriostatic saline provides an adequate level of anesthesia for minor in-office eyelid procedures while allowing for reducing pain associated with medication infusion compared with traditional local anesthetic agents. To assess this, the investigators will recruit 150 patients aged 18 or older undergoing minor eyelid procedures including eyelid biopsies, chalazion removal from outpatient oculoplastics clinics at University of California, San Francisco. Patients will be randomized in a 1:1 fashion to undergo local anesthetic with either 1% lidocaine with 1:100,000 epinephrine or 0.9% bacteriostatic saline. Primary outcome measure will be pain level on a scale of 1-10 with regards to injection and procedure itself. These will be compared between the two groups. The investigators hypothesize that bacteriostatic saline is superior to lidocaine with epinephrine in terms of pain with injection, but will result in a similar pain level during the procedure.

Interventions

DRUG0.9% Bacteriostatic Local Anesthetic Injection

Following research and procedural consent, local anesthetic injection will be carried out using a standard 1 cc of local anesthetic corresponding to the study arm (0.9% bacteriostatic saline or 1% lidocaine with 1:100,000 epinephrine). Prior to anesthetic administration, the procedure site will be cleaned using standard measures. A 30 gauge needle on a 3 centimeter cubed volume syringe will be utilized. Five minutes will be given for local anesthetic to take effect.

DRUG1% Lidocaine with 1:100,000 epinephrine Local Anesthetic Injection

Following research and procedural consent, local anesthetic injection will be carried out using a standard 1 cc of local anesthetic consisting of a commercially available mixture of 1% lidocaine with 1:100,000 epinephrine. Prior to anesthetic administration, the procedure site will be cleaned using standard measures. A 30 gauge needle on a 3 centimeter cubed volume syringe will be utilized. Five minutes will be given for local anesthetic to take effect.

PROCEDUREEyelid Lesion Removal

Following anesthesia administration, patient will proceed with recommended eyelid lesion removal. The procedure site will be cleaned according to standard protocol, and standard technique for lesion removal will be performed, which will vary according to type of lesion but may involve use of Westcott scissors, forceps, #15 or #11 blades or other oculoplastics administration. The exact procedural details will be at the discretion of the surgeon.

Sponsors

University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Masking description

Patient and provider performing procedure will be masked to local anesthesia type

Eligibility

Sex/Gender
ALL
Age
18 Years to 110 Years
Healthy volunteers
No

Inclusion criteria

1. Age \>=18 years old 2. Undergoing clinic-based periocular procedure

Exclusion criteria

1. Any other topical, oral or intravenous sedating medications given alongside procedure 2. Allergy to saline, lidocaine or epinephrine 3. Unable to provide consent due to cognitive impairment

Design outcomes

Primary

MeasureTime frameDescription
Pain on Injection5 minutesPain on a scale of 0-10 during injection process (0 being no pain, 10 being worst pain ever experienced). These will be patient-reported verbally and recorded immediately after injection.
Pain of Procedure10 minutesPain on a scale of 0-10 during procedure (0 being no pain, 10 being worst pain ever experienced). These will be patient-reported verbally and recorded immediately after procedure.

Secondary

MeasureTime frameDescription
Number of Lesions That Needed Additional Anesthesia to Complete Procedure10 minutesNumber of Lesions that Needed Additional Anesthesia to Complete Procedure
Bleeding Level10 minutesPhysician-assessed level of bleeding after procedure (mild, moderate, severe). These will be physician-reported verbally and recorded immediately after procedure.

Countries

United States

Participant flow

Recruitment details

95 patients with 110 lesions were recruited. There were 103 encounters, creating duplicate patients in the two separate groups. The primary unit type analyzed was lesions. Participants had either 1, 2, or 3 lesions. Each lesion was randomized separately. Therefore, one participant could be part of both the bacteriostatic and lidocaine with epinephrine groups.

Participants by arm

ArmCount
Bacteriostatic Saline as Local Anesthesia
Patients receiving bacteriostatic saline as local anesthesia for in-office minor eyelid procedures at University of California, San Francisco Medical Center, Oculoplastics department 0.9% Bacteriostatic Local Anesthetic Injection: Following research and procedural consent, local anesthetic injection will be carried out using a standard 1 cc of local anesthetic corresponding to the study arm (0.9% bacteriostatic saline or 1% lidocaine with 1:100,000 epinephrine). Prior to anesthetic administration, the procedure site will be cleaned using standard measures. A 30 gauge needle on a 3 centimeter cubed volume syringe will be utilized. Five minutes will be given for local anesthetic to take effect. Eyelid Lesion Removal: Following anesthesia administration, patient will proceed with recommended eyelid lesion removal. The procedure site will be cleaned according to standard protocol, and standard technique for lesion removal will be performed, which will vary according to type of lesion but may involve use of Westcott scissors, forceps, #15 or #11 blades or other oculoplastics administration. The exact procedural details will be at the discretion of the surgeon.
55
Bacteriostatic Saline as Local Anesthesia
Patients receiving bacteriostatic saline as local anesthesia for in-office minor eyelid procedures at University of California, San Francisco Medical Center, Oculoplastics department 0.9% Bacteriostatic Local Anesthetic Injection: Following research and procedural consent, local anesthetic injection will be carried out using a standard 1 cc of local anesthetic corresponding to the study arm (0.9% bacteriostatic saline or 1% lidocaine with 1:100,000 epinephrine). Prior to anesthetic administration, the procedure site will be cleaned using standard measures. A 30 gauge needle on a 3 centimeter cubed volume syringe will be utilized. Five minutes will be given for local anesthetic to take effect. Eyelid Lesion Removal: Following anesthesia administration, patient will proceed with recommended eyelid lesion removal. The procedure site will be cleaned according to standard protocol, and standard technique for lesion removal will be performed, which will vary according to type of lesion but may involve use of Westcott scissors, forceps, #15 or #11 blades or other oculoplastics administration. The exact procedural details will be at the discretion of the surgeon.
59
Lidocaine With Epinephrine as Local Anesthesia
Patients receiving lidocaine with epinephrine as local anesthesia for in-office minor eyelid procedures at University of California, San Francisco Medical Center, Oculoplastics department 1% Lidocaine with 1:100,000 epinephrine Local Anesthetic Injection: Following research and procedural consent, local anesthetic injection will be carried out using a standard 1 cc of local anesthetic consisting of a commercially available mixture of 1% lidocaine with 1:100,000 epinephrine. Prior to anesthetic administration, the procedure site will be cleaned using standard measures. A 30 gauge needle on a 3 centimeter cubed volume syringe will be utilized. Five minutes will be given for local anesthetic to take effect. Eyelid Lesion Removal: Following anesthesia administration, patient will proceed with recommended eyelid lesion removal. The procedure site will be cleaned according to standard protocol, and standard technique for lesion removal will be performed, which will vary according to type of lesion but may involve use of Westcott scissors, forceps, #15 or #11 blades or other oculoplastics administration. The exact procedural details will be at the discretion of the surgeon.
48
Lidocaine With Epinephrine as Local Anesthesia
Patients receiving lidocaine with epinephrine as local anesthesia for in-office minor eyelid procedures at University of California, San Francisco Medical Center, Oculoplastics department 1% Lidocaine with 1:100,000 epinephrine Local Anesthetic Injection: Following research and procedural consent, local anesthetic injection will be carried out using a standard 1 cc of local anesthetic consisting of a commercially available mixture of 1% lidocaine with 1:100,000 epinephrine. Prior to anesthetic administration, the procedure site will be cleaned using standard measures. A 30 gauge needle on a 3 centimeter cubed volume syringe will be utilized. Five minutes will be given for local anesthetic to take effect. Eyelid Lesion Removal: Following anesthesia administration, patient will proceed with recommended eyelid lesion removal. The procedure site will be cleaned according to standard protocol, and standard technique for lesion removal will be performed, which will vary according to type of lesion but may involve use of Westcott scissors, forceps, #15 or #11 blades or other oculoplastics administration. The exact procedural details will be at the discretion of the surgeon.
51
Total213

Baseline characteristics

CharacteristicBacteriostatic Saline as Local AnesthesiaLidocaine With Epinephrine as Local AnesthesiaTotal
Age, Continuous
Baseline Population by Population
58.5 years
STANDARD_DEVIATION 18.5
59.8 years
STANDARD_DEVIATION 16.2
59.1 years
STANDARD_DEVIATION 17.4
Baseline Lesion Size3.2 Millimeters
STANDARD_DEVIATION 3.3
3.7 Millimeters
STANDARD_DEVIATION 3.7
3.5 Millimeters
STANDARD_DEVIATION 3.5
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Gender Distribution
Female
42 Participants32 Participants74 Participants
Sex: Female, Male
Gender Distribution
Male
13 Participants16 Participants29 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 550 / 48
other
Total, other adverse events
0 / 550 / 48
serious
Total, serious adverse events
0 / 550 / 48

Outcome results

Primary

Pain of Procedure

Pain on a scale of 0-10 during procedure (0 being no pain, 10 being worst pain ever experienced). These will be patient-reported verbally and recorded immediately after procedure.

Time frame: 10 minutes

Population: Primary unit analyzed was lesions. Because each participant may have been randomized more than once, each participant may have more than one outcome. For this reason, outcome measures are expressed based on lesions rather than participants.

ArmMeasureValue (MEAN)Dispersion
Bacteriostatic Saline as Local AnesthesiaPain of Procedure4.9 score on a scaleStandard Deviation 2.9
Lidocaine With Epinephrine as Local AnesthesiaPain of Procedure2.0 score on a scaleStandard Deviation 2.7
Primary

Pain on Injection

Pain on a scale of 0-10 during injection process (0 being no pain, 10 being worst pain ever experienced). These will be patient-reported verbally and recorded immediately after injection.

Time frame: 5 minutes

Population: Primary unit analyzed was lesions. Because each participant may have been randomized more than once, each participant may have more than one outcome. For this reason, outcome measures are expressed based on lesions rather than participants.

ArmMeasureValue (MEAN)Dispersion
Bacteriostatic Saline as Local AnesthesiaPain on Injection2.8 score on a scaleStandard Deviation 2.4
Lidocaine With Epinephrine as Local AnesthesiaPain on Injection3.6 score on a scaleStandard Deviation 2.6
Secondary

Bleeding Level

Physician-assessed level of bleeding after procedure (mild, moderate, severe). These will be physician-reported verbally and recorded immediately after procedure.

Time frame: 10 minutes

Population: Primary unit analyzed was lesions. Because each participant may have been randomized more than once, each participant may have more than one outcome. For this reason, outcome measures are expressed based on lesions rather than participants.

ArmMeasureGroupValue (NUMBER)
Bacteriostatic Saline as Local AnesthesiaBleeding LevelNumber of Lesions with Mild Bleeding29 Number of lesions
Bacteriostatic Saline as Local AnesthesiaBleeding LevelNumber of Lesions with Moderate Bleeding25 Number of lesions
Bacteriostatic Saline as Local AnesthesiaBleeding LevelNumber of Lesions with Severe Bleeding4 Number of lesions
Bacteriostatic Saline as Local AnesthesiaBleeding LevelNumber of Lesions with Unknown Bleeding Level1 Number of lesions
Lidocaine With Epinephrine as Local AnesthesiaBleeding LevelNumber of Lesions with Unknown Bleeding Level2 Number of lesions
Lidocaine With Epinephrine as Local AnesthesiaBleeding LevelNumber of Lesions with Mild Bleeding33 Number of lesions
Lidocaine With Epinephrine as Local AnesthesiaBleeding LevelNumber of Lesions with Severe Bleeding0 Number of lesions
Lidocaine With Epinephrine as Local AnesthesiaBleeding LevelNumber of Lesions with Moderate Bleeding16 Number of lesions
Secondary

Number of Lesions That Needed Additional Anesthesia to Complete Procedure

Number of Lesions that Needed Additional Anesthesia to Complete Procedure

Time frame: 10 minutes

Population: Primary unit analyzed was lesions. Because each participant may have been randomized more than once, each participant may have more than one outcome. For this reason, outcome measures are expressed based on lesions rather than participants.

ArmMeasureValue (NUMBER)
Bacteriostatic Saline as Local AnesthesiaNumber of Lesions That Needed Additional Anesthesia to Complete Procedure33 lesions
Lidocaine With Epinephrine as Local AnesthesiaNumber of Lesions That Needed Additional Anesthesia to Complete Procedure5 lesions

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026